No profile data available.
Mangalam Drugs & Organics Limited (MANGALAM.NS) is a healthcare company in the drug manufacturing contractors industry, based in Mumbai, India, with about 319 full-time employees.
In Q3 2026 (the quarter ended December 31, 2025) revenue was 583.76 million INR, down 34.1% from a year before. Its market capitalization was 466.46 million INR as of October 1, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 1, 2026.
Mangalam Drugs & Organics Limited, together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India.
466.46 million INR as of October 1, 2026.
Listed companies of a similar size in the same industry (drug manufacturing contractors) include Sunil Healthcare Limited (SUNLOC.BO), Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM.NS), ANG Lifesciences India Limited (ANG.BO), Roopa Industries Limited (ROOPAIND.BO).